Our world is currently grappling with an alarming and escalating issue – the mounting antibiotic resistance of harmful bacteria, indicating a dark reality that experts believe we are already facing. Dating back to approximately eight decades ago, shortly after the widespread use of penicillin, bacteria commenced their evolutionary journey, devising ways to evade the effects of antibiotic medication. This ongoing battle between humans and lethal microbes rages on, however, the field of humanity appears to be persistently losing ground. The phenomenon of antibiotic resistance has been a ‘slow-burning pandemic’ that has been sidelined amidst other health crises. However, the increasing rates of antibiotic resistance coupled with a worrying dearth of novel antibiotics necessitates decisive action and preventative measures, says Christina Yek, a distinguished research physician from the National Institute of Allergy and Infectious Diseases, an arm of the United States National Institutes of Health.
According to the World Health Organization, the resistance of harmful germs to antibiotic treatments constitutes one of the pressing global public health concerns. An estimated 5 million people across the globe succumb to antibiotic-resistant organisms each year. Over 2.8 million antimicrobial-resistant infections are recorded annually in the U.S. alone, inclusive of both hospital-acquired and community-acquired infections.
Rick Martinello, Medical Director of Yale Medicine’s Infection Prevention Program, emphasizes the current situation, “We have transitioned into a post-antibiotic era where effective antibiotics are increasingly sparse.” The increasing drug resistance has bleak implications, including prolonged infections, extended hospitalizations, and an increase in mortality rates.
A recent study revealed that hospital-acquired resistant infections surged by 32% during the COVID-19 pandemic. Particularly concerning is that the resistance patterns were highest among microbes resistant to carbapenems, a commonly used antibiotic group. Of particular concern were several bacteria known to cause severe hospital infections, underscoring the alarming state of antibiotic resistance we are facing.
Despite the surging pandemic, the development and approval of novel antibiotics have stagnated. The sobering realization, as Yek notes, is that resistance is gaining momentum while antibiotic advancement remains static.
Additionally, the healthcare challenges of antibiotic resistance disproportionately affect sections of the society more than others. Data indicate heightened risk and infection rates among individuals with chronic diseases or acute illnesses, as well as socioeconomically and educationally disadvantaged individuals.
Intensifying the severity of the situation is the relative virulence of antibiotic-resistant germs and their adverse outcomes, including higher disability and death rates. These pathogens can infiltrate a patient’s body through hospital procedures and interventions, with risk factors being prolonged hospital stays and recent antibiotic courses.
While the excessive and non-discriminatory dispensing of antibiotics contributes to resistance, so do extensive veterinary and agricultural uses of these drugs. This indiscriminate use, over time, enables survival and multiplication of naturally antibiotic-resistant organisms, leading to the evolution of multi-drug resistant microbes.
In the quest for solutions, scientists continue to search for new drugs and explore artificial intelligence for breakthroughs. Hospitals, meanwhile, are implementing strict protocols for infection prevention; these include good hygiene practices, device disinfection, and reduced antibiotic prescription lengths.
However, reducing antibiotics usage relies not solely on hospital regimes but also on community medical practices. Additionally, organic food consumption can contribute to reduced antibiotic intake, reinforcing the need for mindful practices to preserve the usefulness of these valuable medications.
Source: https://www.nationalgeographic.com/science/article/are-we-in-a-post-antibiotic-era